Ninth Circuit backs district court, tosses Nexus Pharma appeal in compounding drug suit
In a case over who can judge what a copycat drug is, two courts have now said that the FDA holds that exclusive privilege. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
